Boston Scientific Corp (XTER:BSX)
€ 87 1.5 (1.75%) Market Cap: 126.63 Bil Enterprise Value: 134.92 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 79/100

Boston Scientific Corp at Canaccord Genuity Growth Conference Transcript

Aug 08, 2019 / 02:00PM GMT
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst

Hi, good morning. Maybe get started as people file in so that we can get in as many questions here with Boston Scientific. Very happy to have Boston Scientific, a local company but certainly a global company, at the Canaccord conference. Again, I'm Jason Mills, senior medical devices analyst. Very happy to have the Head of Investor Relations, Susie Lisa; and also Lauren as well with her to talk about the business. Thank you very much for coming.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thanks for having us. Yes.

Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst

And hopefully, this is a productive meeting for you guys as well as you tell your story.

Questions & Answers

Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst

Recent news, let's just start there and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot